Multiple sclerosis drug approved for use on NHS in Scotland – Aberdeen Evening Express

The SMC has published advice on several new treatments to be used by NHS Scotland (Anthony Devlin/PA)

The Scottish Medicines Consortium has approved several drugs, including one for a form of multiple sclerosis (MS).

The organisation has published advice on the new treatments to be used by NHS Scotland.

It has given its approval for siponimod (Mayzent) to be used by adult patients who have secondary progressive MS.

Read more at:

Leave a Reply

Your email address will not be published. Required fields are marked *

Font Resize